Explore our whitepapers
Our whitepapers provide a deeper look into the clinical, regulatory and strategic considerations of early-phase development in Australia and the Asia-Pacific. These resources draw on our therapeutic experience and operational data to help sponsors navigate the transition from protocol design to first-in-human trials.
-
Whitepaper
Advancing Central Nervous System Clinical Trials
Summary Central nervous system (CNS) disorders represent one of the… Read more -
Whitepaper
The Global Vaccine Clinical Trials Landscape
Post-COVID Trends and Australia’s Strategic Advantage The global vaccine industry… Read more -
Whitepaper
Streamlining Clinical Trial Start-Up in Australia: A Guide to Faster, Cost-Effective Research
This whitepaper provides an in-depth guide to accelerating clinical trial… Read more -
Whitepaper
The Benefits of US Biotechs Conducting Clinical Trials in Australia
Australia has quickly become a top destination for US biotech… Read more